Seeking Alpha
 

Simcere Pharmaceutical Group (SCR)

- NYSE
SCR is defunct.
  • Mar. 11, 2013, 12:56 PM
    Midday top 10 gainers: CALI +52%. BOSC +45%. ESYS +30%. CBMX +25%. LAS +25%. PAMT +15%. FONR +15%. SCR +15%. SGOC +15%. RWC +14%.
    Midday top 10 losers: AEZS -21%. NSU -11%. CSIQ -11%. SPEX -11%. FREE -10%. DKS -10%. CERE -10%. CNIT -9%. ONP -9%. RDCM -8%.
    | Comment!
  • Mar. 11, 2013, 8:29 AM
    Simcere Pharmaceutical (SCR) jumps 16.2% to $9.25 after the Chinese company receives a buyout offer of $9.56/ADS from a consortium led by its chairman, Jinsheng Ren. The bid represents a premium of 19% on Simcere's Friday close of $7.96 and values the firm at $500M. The firm has appointed a committee of independent directors to analyze the offer. (PR)
    | Comment!
Visit Seeking Alpha's
Company Description
Simcere Pharmaceutical Group is engaged in the research, development, manufacture and distribution of pharmaceutical products in the People's Republic of China.
Sector: Healthcare
Country: China